Cat.NO.:A1481647,A183233,A1481647,A183233 Purity:98+%,98%,98+%,98%
Product Details of [ 100189-84-2 ]
CAS No. : | 100189-84-2 |
Formula : |
C8H8Br2 |
M.W : |
263.96
|
SMILES Code : | CC1=CC(Br)=CC(C)=C1Br |
MDL No. : | MFCD00079745 |
Boiling Point : | No data available |
InChI Key : | XXFGKGMZLZIPCN-UHFFFAOYSA-N |
Pubchem ID : | 2758047 |
Safety of [ 100189-84-2 ]
GHS Pictogram: | ![]() |
Signal Word: | Warning |
Hazard Statements: | H302+H312+H332-H315-H319-H335 |
Precautionary Statements: | P261-P280-P305+P351+P338 |
Computational Chemistry of [ 100189-84-2 ] Show Less
Physicochemical Properties
Num. heavy atoms | 10 |
Num. arom. heavy atoms | 6 |
Fraction Csp3 | 0.25 |
Num. rotatable bonds | 0 |
Num. H-bond acceptors | 0.0 |
Num. H-bond donors | 0.0 |
Molar Refractivity | 51.77 |
TPSA ?
Topological Polar Surface Area: Calculated from |
0.0 Ų |
Lipophilicity
Log Po/w (iLOGP)?
iLOGP: in-house physics-based method implemented from |
2.75 |
Log Po/w (XLOGP3)?
XLOGP3: Atomistic and knowledge-based method calculated by |
4.79 |
Log Po/w (WLOGP)?
WLOGP: Atomistic method implemented from |
3.83 |
Log Po/w (MLOGP)?
MLOGP: Topological method implemented from |
4.39 |
Log Po/w (SILICOS-IT)?
SILICOS-IT: Hybrid fragmental/topological method calculated by |
4.1 |
Consensus Log Po/w?
Consensus Log Po/w: Average of all five predictions |
3.97 |
Water Solubility
Log S (ESOL):?
ESOL: Topological method implemented from |
-4.94 |
Solubility | 0.00304 mg/ml ; 0.0000115 mol/l |
Class?
Solubility class: Log S scale |
Moderately soluble |
Log S (Ali)?
Ali: Topological method implemented from |
-4.52 |
Solubility | 0.00794 mg/ml ; 0.0000301 mol/l |
Class?
Solubility class: Log S scale |
Moderately soluble |
Log S (SILICOS-IT)?
SILICOS-IT: Fragmental method calculated by |
-4.88 |
Solubility | 0.0035 mg/ml ; 0.0000132 mol/l |
Class?
Solubility class: Log S scale |
Moderately soluble |
Pharmacokinetics
GI absorption?
Gatrointestinal absorption: according to the white of the BOILED-Egg |
Low |
BBB permeant?
BBB permeation: according to the yolk of the BOILED-Egg |
Yes |
P-gp substrate?
P-glycoprotein substrate: SVM model built on 1033 molecules (training set) |
No |
CYP1A2 inhibitor?
Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set) |
Yes |
CYP2C19 inhibitor?
Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set) |
No |
CYP2C9 inhibitor?
Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set) |
Yes |
CYP2D6 inhibitor?
Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set) |
Yes |
CYP3A4 inhibitor?
Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set) |
No |
Log Kp (skin permeation)?
Skin permeation: QSPR model implemented from |
-4.51 cm/s |
Druglikeness
Lipinski?
Lipinski (Pfizer) filter: implemented from |
1.0 |
Ghose?
Ghose filter: implemented from |
None |
Veber?
Veber (GSK) filter: implemented from |
0.0 |
Egan?
Egan (Pharmacia) filter: implemented from |
0.0 |
Muegge?
Muegge (Bayer) filter: implemented from |
1.0 |
Bioavailability Score?
Abbott Bioavailability Score: Probability of F > 10% in rat |
0.55 |
Medicinal Chemistry
PAINS?
Pan Assay Interference Structures: implemented from |
0.0 alert |
Brenk?
Structural Alert: implemented from |
0.0 alert: heavy_metal |
Leadlikeness?
Leadlikeness: implemented from |
No; 1 violation:MW<1.0 |
Synthetic accessibility?
Synthetic accessibility score: from 1 (very easy) to 10 (very difficult) |
1.52 |
Application In Synthesis of [ 100189-84-2 ]
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
- Downstream synthetic route of [ 100189-84-2 ]
[ 100189-84-2 ] Synthesis Path-Downstream 1~35
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
72% | 4-Bromo-2,6-dimethylaniline (6.00 g, 30 mmol) was suspended in 48% HBr aqueous solution (20 mL), NaNO 2 (2.28 g, 33 mmol) dissolved in water at -10 C. was added and stirred for 1 hour And sulfamic acid (0.58 g, 6 mmol) was added. This was treated with FeSO 4 .7H 2 O (4.17 g, 15 mmol) in 48% HBr aqueous solution (20 mL) and heated gradually to 80 C., and the mixture was stirred at 80 C. for 1 hour. Water was added to the mixture, the mixture was extracted with hexane, and the organic phase was dried with anhydrous Na 2 SO 4, then the solvent was removed under reduced pressure. Purification with medium pressure (silica gel, hexane) gave 2,5-dibromo-m-xylene (6.19 g, 72% yield). | |
72% | 4-Bromo-2,6-dimethylaniline (6.00 g, 30 mmol) was suspended in 48% HBr aqueous solution (20 mL), NaNO 2 (2.28 g, 33 mmol) dissolved in water at -10 C. was added and stirred for 1 hour And sulfamic acid (0.58 g, 6 mmol) was added. This was treated with FeSO 4 .7H 2 O (4.17 g, 15 mmol) in 48% HBr aqueous solution (20 mL) and heated gradually to 80 C., and the mixture was stirred at 80 C. for 1 hour. Water was added to the mixture, the mixture was extracted with hexane, and the organic phase was dried with anhydrous Na 2 SO 4, then the solvent was removed under reduced pressure. Purification with medium pressure (silica gel, hexane) gave 2,5-dibromo-m-xylene (6.19 g, 72% yield). |
[2]Patent: JP2018/90535,2018,A .Location in patent: Paragraph 0072; 0073; 0082; 0083.
[3]Patent: JP2018/90536,2018,A .Location in patent: Paragraph 0098; 0099; 0100; 0101.
[4]Chemistry – An Asian Journal,2020,vol. 15,p. 524 – 530.
[5]Journal of Porphyrins and Phthalocyanines,2010,vol. 14,p. 804 – 814.
[6]Journal of Organic Chemistry,2012,vol. 77,p. 2074 – 2079.
[7]Recueil des Travaux Chimiques des Pays-Bas,1906,vol. 25,p. 175.
Recueil des Travaux Chimiques des Pays-Bas,1909,vol. 28,p. 93.
[8]Bulletin of the Chemical Society of Japan,1971,vol. 44,p. 2248 – 2253.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
47% | Step 1: A solution of <strong>[100189-84-2]2,5-dibromoxylene</strong> (2.0 g, 7.6 mmol) in DCM (20 ml) was treated with n-BuLi (2.5 M solution in hexane, 3 ml, 1.0 equiv.) at -78C. After stirring for 1h, DMF (1.8 ml, 23 mmol, 3 eq.) was added and the solution was allowed to warm to room temperature. It was acidified to pH 2 with 5% hydrochloric acid and extracted with diethyl ether (3×50 ml). The combined organic phase was dried and evaporated and the residue was purified by column chromatography using PE:EA = 10:1 as eluent to give 4-bromo-3,5-dimethylbenzaldehyde (0.76 g, yield: 47%). | |
A solution of <strong>[100189-84-2]2,5-dibromoxylene</strong> (8.0 g, 30.3 mmol) in diethyl ether (120 mL) is cooled to -78 C. and then treated with n-buthyllithium (20 mL, 1.6 M in hexane). After stirring for 40 min, DMF (6 mL) is slowly added. The mixture is warmed to rt and stirred for 1 h. The mixture is cooled again to -78 C. before another portion of n-butyllithium (5 mL) is added. The reaction mixture is allowed to warm to rt and stirred for another hour. The reaction is quenched by adding 5% aq. HCl. The mixture is extracted with EA, and the extract is concentrated in vacuo. The crude product is purified by CC on silica gel eluting with heptane:EA 5:1 to give 4-bromo-3,5-dimethyl-benzaldehyde (8.2 g) as a white soft solid. | ||
A solution of <strong>[100189-84-2]2,5-dibromoxylene</strong> (8.0 g, 30.3 mmol) in diethyl ether (120 ml_) is cooled to -78C and then treated with n-buthyllithium (20 ml_, 1.6 M in hexane). After stirring for 40 min, DMF (6 ml_) is slowly added. The mixture is warmed to rt and stirred for 1 h. The mixture is cooled again to -78C before another portion of n- butyllithium (5 ml_) is added. The reaction mixture is allowed to warm to rt and stirred for another hour. The reaction is quenched by adding 5% aq. HCI. The mixture is extracted with EA, and the extract is concentrated in vacuo. The crude product is purified by CC on silica gel eluting with heptane:EA 5:1 to give 4-bromo- 3,5-dimethyl-benzaldehyde (8.2 g) as a white soft solid. |
Reviews
There are no reviews yet.